A study was performed to determine the long-term visual results after
laser photocoagulation in diabetic maculopathy. One hundred and four e
yes of 56 diabetic patients underwent modified grid laser photocoagula
tion for diabetic maculopathy according to the protocol of the Europea
n Study Group on Diabetic Eye Complications and the Early Treatment Di
abetic Retinopathy Study. Follow-up ranged from 12 months to 2.5 years
. Eyes with visual acuity less than 0.2 before treatment were included
in group A, those with visual aquity of 0.3-0.6 in group B and eyes w
ith visual acuity more than 0.7 were included in group C. At 1 year, 7
9.4% of the eyes of group A improved or preserved their visual acuity,
with 38.9% of group B and 88.2% of group C; at 2 years, 86.6% of grou
p A, 30% of group B and 66.7% of group C and at 2.5 years 85.7% of gro
up A, 27.3% of group B and 75% of group C improved or preserved their
visual acuity. The percentages of positive results concerning the visu
al acuity for groups A and C were significantly greater compared with
those for group B. These results suggest that modified grid laser phot
ocoagulation for the management of diabetic maculopathy is an effectiv
e procedure in 'early treated' eyes (visual aquity greater than or equ
al to 0.7). It contributes to improve a little or to preserve low visi
on but it did not affect the natural course of disease in the rest of
the eyes.